Search Within

Rebecca Teng

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (3)
Groups
  1. Molecular Imaging and Therapy Service (8)
  2. Radiology, Department of (8)
  3. Department of Medicine (6)
  4. GSK Faculty (6)
  5. Medical Physics (6)
  6. Solid Tumor Oncology Division (6)

More Groups

People
  1. Wolfgang Weber (7)
  2. Eileen O'Reilly (4)
  3. Heiko Schoder (4)
  4. Jason Lewis (4)
  5. Joseph O'Donoghue (4)
  6. Kimiteru Ito (4)

More People

Years
  1. 2019 (3)
  2. 2018 (1)
  3. 2017 (4)
Publications
  1. Journal of Nuclear Medicine (5)
  2. Cancer Research (1)
  3. Clinical Cancer Research (1)
  4. European Journal of Nuclear Medicine and Molecular Imaging (1)
Publishers
  1. Society of Nuclear Medicine (5)
  2. American Association for Cancer Research (2)
  3. Springer (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Retooling a blood-based biomarker: Phase I assessment of the high-affinity CA19-9 antibody HuMAB-5B1 for immuno-PET imaging of pancreatic cancer
    Journal Article

    Lohrmann, C.; O'Reilly, E. M.; O'Donoghue, J. A.; Pandit-Taskar, N.; Carrasquillo, J. A.; Lyashchenko, S. K.; Ruan, S.; Teng, R.; Scholz, W.; Maffuid, P. W.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Prognostic value of baseline metabolic tumor volume measured on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in melanoma patients treated with ipilimumab therapy
    Journal Article

    Ito, K.; Schòˆder, H.; Teng, R.; Humm, J. L.; Ni, A.; Wolchok, J. D.; Weber, W. A.
    European Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save
  • (18)F-FDG PET/CT for monitoring of ipilimumab therapy in patients with metastatic melanoma
    Journal Article

    Ito, K.; Teng, R.; Schòˆder, H.; Humm, J. L.; Ni, A.; Michaud, L.; Nakajima, R.; Yamashita, R.; Wolchok, J. D.; Weber, W. A.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Phase I dose escalation study of 177Lu-HuMab-5B1 (MVT-1075) in combination with MVT-5873 as radioimmunotherapy (RIT) in subjects with relapsed / refractory pancreatic cancer or other CA19-9+malignancies
    Meeting Abstract

    O'Reilly, E. A.; Lohrmann, C.; O'Donoghue, J. A.; Borazanci, E.; Estrella, H.; Teng, R.; Melink, T.; Dorr, K.; Kearns, C.; Peterson, M.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Biodistribution and radiation rose estimates for (89)Zr-DFO-HuMab-5B1 (MVT-2163) in CA19-9 positive cancer: First-in-man results
    Meeting Abstract

    O'Donoghue, J.; Lohrmann, C.; O'Reilly, E.; Yu, K.; Lowery, M.; Lyashchenko, S.; Pandit-Taskar, N.; Ruan, S.; Wu, L.; Teng, R.; more...
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • First-in-human study of (89)Zr-DFO-HuMab-5B1 (MVT-2163) PET/CT imaging with and without HuMab-5B1 (MVT-5873) in patients with pancreatic cancer and other CA 19-9 positive malignancies
    Meeting Abstract

    Lohrmann, C.; O'Reilly, E.; ODonoghue, J.; Yu, K. H.; Pandit-Taskar, N.; Lyashchenko, S.; Ruan, S.; Wu, J.; DeNoble, P.; Carrasquillo, J.; more...
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • F-18 FDG PET/CT for monitoring immunotherapy with ipilimumab in patients with advanced melanoma
    Meeting Abstract

    Ito, K.; Teng, R.; Schoder, H.; Weber, W.
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Prognostic value of metabolic tumor volume on pretreatment F-18 FDG PET/CT in patients with advanced melanoma treated with ipilimumab
    Meeting Abstract

    Ito, K.; Teng, R.; Schoder, H.; Weber, W.
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save